Gyomor- és nyelőcsőrák: vizsgálatok itt: Dél-Korea
89 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Where
- Daegu, Hwasun-gun, Seongnam-si, Seoul
- Életkor
- 18 év and over
- People
- 2130 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00 - 1. fázisTaking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Busan, Cheongju-si, Jinju, Seoul
- Életkor
- 18 év and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - 3. fázisFut, nem toborozA Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- BukGu, GangnamGu, SeodaemunGu, Seongnam-si, Seoul, SongpaGu
- Életkor
- 18 év and over
- People
- 351 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT07043400 · EU 2025-522862-58-00 - 2. fázisTaking peopleA Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
- Where
- Daegu, Hwasun, Seongnam-si, Seoul
- Életkor
- 18 év and over
- People
- 146 worldwide
- Run by
- Toray Industries, Inc
See details and how to joinNCT06038578 - 1/2. fázisTaking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - 1/2. fázisTaking peopleA Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05319730 · EU 2023-505189-26-00 - 2. fázisTaking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Gyeonggi-do, Seoul
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 1/2. fázisTaking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - 1/2. fázisTaking peopleClinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- Where
- Cheongju-si, Incheon, Jinju, Seongnam-si, Seoul, Suwon, Ulsan
- Életkor
- 18 év and over
- People
- 147 worldwide
- Run by
- Yuhan Corporation
See details and how to joinNCT05523947 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Seoul
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- BundangGu SeongnamSi, Cheongju-si, GangnamGu, SeodaemunGu, Seongnam-si, Seoul, SongpaGu
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - 1. fázisTaking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Guro-gu, Jongno-gu, Seocho-gu, Seodaemun-gu, Seongnam-si
- Életkor
- 18 év and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Incheon, Namdong-gu, Seoul
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 1. fázisNot yet taking people in Dél-KoreaSKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- SK Life Science, Inc.
See details and how to joinNCT07812805 - 1/2. fázisTaking peopleSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 210 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06445972 · EU 2023-509306-29-00 - 1/2. fázisFut, nem toborozA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Gyeonggi-do, Seoul
- Életkor
- 18 év and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - No phaseTaking peopleMalignant Gastric Outlet Obstruction Study With Stomach Partitioning (GO-PART)
- Where
- Changwon
- Életkor
- 20 év to 85 év
- People
- 144
- Run by
- Gyeongsang National University Hospital
See details and how to joinNCT07749326 - 3. fázisTaking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Cheongju-si, Daegu, Goyang-si, Hwasun-gun, Incheon, Jeonju, Seongnam, Seongnam-si, Seoul
- Életkor
- 18 év and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - No phaseTaking peopleSurgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
- Where
- Seoul
- Életkor
- 20 év to 69 év
- People
- 120
- Run by
- Korea University Anam Hospital
See details and how to joinNCT04284943 - 1. fázisTaking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Cheongju-si, Goyang-si, Seoul
- Életkor
- 18 év and over
- People
- 1006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - 2. fázisTaking peoplePerioperative Therapies in Locally Advanced Unresectable Gastric Cancer
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 100
- Run by
- Jeeyun Lee
See details and how to joinNCT06630130 - 1. fázisTaking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Goyang-si, Seongnam, Seoul
- Életkor
- 18 év and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - 1. fázisTaking peopleBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- SillaJen, Inc.
See details and how to joinNCT05768932 - 1/2. fázisTaking peopleClinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 80
- Run by
- Yuhan Corporation
See details and how to joinNCT06975410 - No phaseTaking peoplePULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 53
- Run by
- Samsung Medical Center
See details and how to joinNCT07607119